Tonix Pharmaceuticals Holding Corp (TNXP)
0.1418
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.1404
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Debt to Equity Ratio: 0.2016 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.2016 |
| March 31, 2024 | 0.083 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.0844 |
| September 30, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2023
0.2016
Maximum
Jun 2024
0.0922
Average
0.0837
Median
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 2.232 |
| Geovax Labs Inc | -0.0616 |
| Abbott Laboratories | 0.3764 |
| SIGA Technologies Inc | 0.00 |
| Chimerix Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 70.31M |
| Total Liabilities (Quarterly) | 28.20M |
| Shareholders Equity (Quarterly) | 42.10M |
| Current Ratio | 1.147 |
| Net Debt Paydown Yield | -9.21% |